Ekso Bionics Holdings Q3 EPS $(0.10), Inline, Sales $4.13M Miss $5.55M Estimate
Portfolio Pulse from Benzinga Newsdesk
Ekso Bionics Holdings reported Q3 EPS of $(0.10), meeting analyst expectations, but sales of $4.13M missed the $5.55M estimate, marking a 10.38% decrease from last year.
October 28, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Ekso Bionics Holdings reported Q3 EPS of $(0.10), meeting expectations, but sales of $4.13M missed the $5.55M estimate, a 10.38% decrease from last year.
While Ekso Bionics met EPS expectations, the significant miss on sales and the year-over-year decline in revenue are likely to negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100